Literature DB >> 12559407

Modulation of cell-phenotype during in vitro aging. Glycosaminoglycan biosynthesis by skin fibroblasts and corneal keratocytes.

N Isnard1, I Fodil, L Robert, G Renard.   

Abstract

The aim of this study was to compare keratocyte and fibroblast phenotypes during in vitro aging by comparing their biosynthesis of glycosaminoglycans using explant and cell cultures. Human skin and corneal explant cultures were realised with Dulbecco Modified Eagle's medium containing 3H glucosamine. Sequential cell cultures were studied at different passages for GAGs biosynthesis by 3H glucosamine incorporation followed by selective degradation with specific hydrolases. Radioactivity was determined and each GAG fraction evaluated. KS and DS are the major components synthesised by corneal explant culture. During in vitro aging, keratocytes synthesised 41% less KS between passages 4-9 with a decrease by 26% of the proportion of DS observed in the same conditions. In skin explant cultures, as expected the major components are CS and hyaluronan (HA). In the first cell passage studied compared with skin organ cultures we could notice a strong decrease of the proportions of DS and KS compensated by an increase of the proportion of HA. During the successive passages of fibroblasts, the proportions of DS and HS decreased (-30 and -62%, respectively) and those of KS increased (+90%). These results indicate that there remain measurable differences between keratocyte and fibroblast phenotypes as far as GAG-synthesis is concerned all though the successive passages, starting from explant cultures and up to the limits of in vitro cell passages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12559407     DOI: 10.1016/s0531-5565(02)00120-1

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  1 in total

1.  Glycosaminoglycans in the human cornea: age-related changes.

Authors:  Elena Pacella; Fernanda Pacella; Giulio De Paolis; Francesca Romana Parisella; Paolo Turchetti; Giulia Anello; Carlo Cavallotti
Journal:  Ophthalmol Eye Dis       Date:  2015-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.